Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Panion & BF Biotech stock price, quote, forecast and news

1760.TW
TW0001760007

Price

93.70 TWD
Today +/-
+0 TWD
Today %
+0 %
P

Panion & BF Biotech Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Panion & BF Biotech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Panion & BF Biotech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Panion & BF Biotech’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Panion & BF Biotech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Panion & BF Biotech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Panion & BF Biotech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Panion & BF Biotech’s growth potential.

Panion & BF Biotech Revenue, EBIT and net profit per share

DatePanion & BF Biotech RevenuePanion & BF Biotech EBITPanion & BF Biotech Net Income
2024e2.09 B TWD215.22 M TWD139.93 M TWD
20231.88 B TWD156.83 M TWD77.22 M TWD
20222.4 B TWD413.96 M TWD182.35 M TWD
20211.9 B TWD165.34 M TWD104.4 M TWD
20201.57 B TWD104.5 M TWD27.9 M TWD
20191.57 B TWD223.93 M TWD161.33 M TWD
20181.41 B TWD212.54 M TWD159.17 M TWD
20171.21 B TWD144.72 M TWD90.54 M TWD
20161.05 B TWD129.62 M TWD89.72 M TWD
20151.21 B TWD119.97 M TWD73 M TWD
20141.01 B TWD64.4 M TWD48.27 M TWD
2013857.1 M TWD13.9 M TWD18.1 M TWD
2012674.9 M TWD-47.7 M TWD-40.6 M TWD
2011584.2 M TWD-47.4 M TWD-36.3 M TWD
2010524.8 M TWD-55.4 M TWD-39.3 M TWD
2009559.4 M TWD3.9 M TWD5.1 M TWD
2008482.8 M TWD-50.9 M TWD10.6 M TWD
2007545.5 M TWD7.8 M TWD3.4 M TWD
2006473.6 M TWD-168.2 M TWD-151.9 M TWD
2005460.9 M TWD-78.1 M TWD-15.1 M TWD
2004477 M TWD-28.6 M TWD-21.2 M TWD

Panion & BF Biotech Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B TWD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B TWD)EBIT (M TWD)EBIT MARGIN (%)NET INCOME (M TWD)NET INCOME GROWTH (%)DIV. (TWD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e
0.470.480.460.470.550.480.560.520.580.670.861.011.211.051.211.411.571.571.92.41.882.09
-1.49-3.562.8315.22-11.5615.98-6.2611.4515.4127.1518.3218.84-12.9515.5416.1711.72-0.3221.2426.14-21.5610.95
59.1553.6749.3544.4053.7649.5953.1355.9251.5451.4854.1460.0661.0056.0557.2657.0354.9351.9147.9754.9651.78-
0.280.260.230.210.290.240.30.290.30.350.460.610.740.590.690.80.860.810.911.320.970
30-28-78-1687-503-55-47-471364119129144212223104165413156215
6.38-5.87-16.96-35.521.28-10.370.54-10.50-8.05-6.971.526.319.8812.3011.8815.0614.186.638.6817.228.2910.30
30-21-15-1513105-39-36-4018487289901591612710418277139
--170.00-28.57906.67-101.99233.33-50.00-880.00-7.6911.11-145.00166.6750.0023.611.1276.671.26-83.23285.1975.00-57.6980.52
----------------------
----------------------
43.446.550.950.950.950.950.955.856.356.460.668.1968.1769.4869.4877.8278.2378.1879.1885.8385.790
----------------------
Details

Keystats

ⓘ

Revenue and Growth

The Panion & BF Biotech Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Panion & BF Biotech is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M TWD)RECEIVABLES (M TWD)OTHER REC. (M TWD)INVENTORIES (M TWD)OTHER CURRENT LIAB. (M TWD)CURRENT ASSETS (M TWD)TANGIBLE ASSETS (M TWD)LONG-T. INVEST. (M TWD)LONG-T. REC. (M TWD)INTANGIBLE ASSETS (M TWD)GOODWILL (M TWD)OTHER NON-CURRENT ASSETS (M TWD)NON-CURRENT ASSETS (M TWD)TOTAL ASSETS (M TWD)LIABILITIESCOMMON STOCK (M TWD)ADDITIONAL PAID-IN CAPITAL (M TWD)RETAINED EARNINGS (M TWD)OTHER EQUITY (M TWD)UNREAL. GAINS/LOSSES (M TWD)EQUITY (M TWD)LIABILITIES (M TWD)PROVISIONS (M TWD)OTHER SHORT-TERM LIAB. (M TWD)SHORT-TERM DEBTS (M TWD)LONG-TERM DEBT PORTION (M TWD)SHORT-TERM REC. (M TWD)LONG-T. LIAB. (M TWD)DEFERRED TAXES (M TWD)OTHER LIAB. (M TWD)LONG-T. LIABILITIES (M TWD)DEBT (M TWD)TOTAL CAPITAL (M TWD)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Panion & BF Biotech provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Panion & BF Biotech's financial health and stability.

Assets

Panion & BF Biotech's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Panion & BF Biotech must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Panion & BF Biotech after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Panion & BF Biotech's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M TWD)DEPRECIATION (M TWD)DEFERRED TAXES (M TWD)CHANGES IN WORKING CAPITAL (M TWD)NON-CASH ITEM (M TWD)PAID INTEREST (M TWD)PAID TAXES (M TWD)NET CASH FLOW FROM OPERATING ACTIVITIES (M TWD)CAPITAL EXPENDITURES (M TWD)CASH FLOW FROM INVESTING ACTIVITIES (M TWD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M TWD)INTEREST INCOME AND EXPENSES (M TWD)NET DEBT CHANGE (M TWD)NET CHANGE IN EQUITY (M TWD)CASH FLOW FROM FINANCING ACTIVITIES (M TWD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M TWD)TOTAL DIVIDENDS PAID (M TWD)NET CHANGE IN CASH FLOW (M TWD)FREE CASH FLOW (M TWD)SHARE-BASED COMPENSATION (M TWD)
20032004200520062007200820092010201120122013201420152016201720182019202020212022
30-21-15-151171-52-46-532374116129143244226000
152022232422221720202325324241416884143163
-5-6-4-11-2010120-10000000000
-53-27-5048-35-817-27-36911-23-1367-71-222-235-21547-104
2627-2043-3242336252928045-101631272797
444689656650000014147
382400027112334376775947676109
13-7-68-46-164774-13-3648676581771137890-14401489
-30-182-18-13-11-6-15-187-37-26-16-50-57-77-23-39-111-101-170-198
-36-208-2426-14-11-9-175-37-27-27-89-90-67-20-55-160-686-215-144
-6-25-639-3-45110-1-10-38-32103-15-49-585-4554
00000000000000000000
1415382169-23-7913142-7-33900000-20783-779-28
0760000040043580200471006280
13226821558-25-1217043171422-3-40-55355-160643-217-167
-1-30-149-267-1019-517030-1-2-1-12-10
000000000000-7-45-55-115-138-138-53-128
-1011-10-6281453-24-28-77516-376033374-230-54-31185
-17.6-189.9-86.5-60.1-27.640.459.1-201.4-73.5-22.669.625.340.7499.3490.3139.07-20.74-115.72231.22291.23
00000000000000000000

Panion & BF Biotech stock margins

The Panion & BF Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Panion & BF Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Panion & BF Biotech.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Panion & BF Biotech's sales revenue. A higher gross margin percentage indicates that the Panion & BF Biotech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Panion & BF Biotech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Panion & BF Biotech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Panion & BF Biotech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Panion & BF Biotech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Panion & BF Biotech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Panion & BF Biotech Margin History

Panion & BF Biotech Gross marginPanion & BF Biotech Profit marginPanion & BF Biotech EBIT marginPanion & BF Biotech Profit margin
2024e51.78 %10.31 %6.7 %
202351.78 %8.33 %4.1 %
202254.97 %17.26 %7.6 %
202147.98 %8.7 %5.49 %
202051.89 %6.66 %1.78 %
201954.91 %14.23 %10.25 %
201857.03 %15.09 %11.3 %
201757.27 %11.94 %7.47 %
201656.09 %12.35 %8.55 %
201561.07 %9.96 %6.06 %
201460.04 %6.35 %4.76 %
201354.23 %1.62 %2.11 %
201251.55 %-7.07 %-6.02 %
201151.64 %-8.11 %-6.21 %
201056 %-10.56 %-7.49 %
200953.13 %0.7 %0.91 %
200849.61 %-10.54 %2.2 %
200753.73 %1.43 %0.62 %
200644.51 %-35.52 %-32.07 %
200549.4 %-16.95 %-3.28 %
200453.67 %-6 %-4.44 %

Panion & BF Biotech Stock Sales Revenue, EBIT, Earnings per Share

The Panion & BF Biotech earnings per share therefore indicates how much revenue Panion & BF Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Panion & BF Biotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Panion & BF Biotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Panion & BF Biotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Panion & BF Biotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Panion & BF Biotech Revenue, EBIT and net profit per share

DatePanion & BF Biotech Sales per SharePanion & BF Biotech EBIT per sharePanion & BF Biotech Earnings per Share
2024e24.34 TWD0 TWD1.63 TWD
202321.94 TWD1.83 TWD0.9 TWD
202227.95 TWD4.82 TWD2.12 TWD
202124.01 TWD2.09 TWD1.32 TWD
202020.06 TWD1.34 TWD0.36 TWD
201920.12 TWD2.86 TWD2.06 TWD
201818.1 TWD2.73 TWD2.05 TWD
201717.45 TWD2.08 TWD1.3 TWD
201615.1 TWD1.87 TWD1.29 TWD
201517.68 TWD1.76 TWD1.07 TWD
201414.88 TWD0.94 TWD0.71 TWD
201314.14 TWD0.23 TWD0.3 TWD
201211.97 TWD-0.85 TWD-0.72 TWD
201110.38 TWD-0.84 TWD-0.64 TWD
20109.41 TWD-0.99 TWD-0.7 TWD
200910.99 TWD0.08 TWD0.1 TWD
20089.49 TWD-1 TWD0.21 TWD
200710.72 TWD0.15 TWD0.07 TWD
20069.3 TWD-3.3 TWD-2.98 TWD
20059.06 TWD-1.53 TWD-0.3 TWD
200410.26 TWD-0.62 TWD-0.46 TWD

Panion & BF Biotech business model

Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech is one of the most popular companies on Eulerpool.com.

Panion & BF Biotech SWOT Analysis

Strengths

Panion & BF Biotech Inc has several key strengths that contribute to its success in the market. These strengths include:

  • Strong R&D capabilities in biotechnology
  • Well-established network and collaborations with key industry players
  • Strong financial position and solid revenue growth
  • Wide range of high-quality products for animal health

Weaknesses

Despite its strengths, Panion & BF Biotech Inc also faces certain weaknesses that need to be addressed to maintain competitiveness:

  • Reliance on a limited number of suppliers for critical raw materials
  • Limited geographic presence, primarily focused on domestic markets
  • Challenges in regulatory compliance and navigating complex approval processes

Opportunities

Panion & BF Biotech Inc can leverage the following opportunities to further expand its business and market share:

  • Increasing demand for animal health products globally
  • Exploring untapped international markets for product expansion
  • Growing trend towards organic and natural products in the animal healthcare industry

Threats

Panion & BF Biotech Inc must be aware of the potential threats that could negatively impact its growth and profitability:

  • Intense competition from established and emerging players in the industry
  • Changes in government regulations and policies affecting the animal healthcare sector
  • Potential economic downturn or market fluctuations

Panion & BF Biotech historical P/E ratio, EBIT, and P/S ratio.

Panion & BF Biotech shares outstanding

The number of shares was Panion & BF Biotech in 2023 — This indicates how many shares 85.791 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Panion & BF Biotech earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Panion & BF Biotech's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Panion & BF Biotech’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Panion & BF Biotech's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Panion & BF Biotech Stock splits

In Panion & BF Biotech's history, there have been no stock splits.

Panion & BF Biotech dividend history and estimates

In 2023, Panion & BF Biotech paid a dividend amounting to 2 TWD. Dividend means that Panion & BF Biotech distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Panion & BF Biotech provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Panion & BF Biotech’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Panion & BF Biotech's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Panion & BF Biotech Dividend History

DatePanion & BF Biotech Dividend
2024e2.02 TWD
20232 TWD
20221.5 TWD
20210.2 TWD
20201.69 TWD
20191.73 TWD
20180.98 TWD
20170.8 TWD
20160.68 TWD
20150.11 TWD

Panion & BF Biotech dividend payout ratio

In 2023, Panion & BF Biotech had a payout ratio of 186.3%. The payout ratio indicates the percentage of the company's profits that Panion & BF Biotech distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Panion & BF Biotech represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Panion & BF Biotech could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Panion & BF Biotech's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Panion & BF Biotech Payout Ratio History

DatePanion & BF Biotech Payout ratio
2024e90.6 %
2023186.3 %
202270.6 %
202114.9 %
2020473.4 %
201983.83 %
201848.02 %
201761.67 %
201652.68 %
201510.59 %
2014186.3 %
2013186.3 %
2012186.3 %
2011186.3 %
2010186.3 %
2009186.3 %
2008186.3 %
2007186.3 %
2006186.3 %
2005186.3 %
2004186.3 %
Unfortunately, there are currently no price targets and forecasts available for Panion & BF Biotech.

Panion & BF Biotech latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20231.2 TWD0.09 TWD (-92.49 %)2023 Q3
6/30/20230.98 TWD0.2 TWD (-79.58 %)2023 Q2
3/31/20231.97 TWD0.26 TWD (-86.79 %)2023 Q1
12/31/20221.76 TWD-1.13 TWD (-164.14 %)2022 Q4
9/30/20220.85 TWD0.91 TWD (7.24 %)2022 Q3
6/30/20220.87 TWD1.88 TWD (117.19 %)2022 Q2
3/31/20220.55 TWD0.46 TWD (-16.36 %)2022 Q1
12/31/20211.04 TWD-0.1 TWD (-109.63 %)2021 Q4
9/30/20211.12 TWD0.77 TWD (-31.32 %)2021 Q3
6/30/20210.99 TWD0.96 TWD (-2.41 %)2021 Q2
1
2
3

Panion & BF Biotech list of shareholders

%
Name
Stocks
Change
Date
3.86 % Li (Kuo Feng-c)3,312,00001/31/2024
2.51 % The Vanguard Group, Inc.2,150,11903/31/2024
2.19 % Zhen (Si Han)1,881,00001/31/2024
18.43 % Pan-You Enterprise15,799,000-10,0003/31/2024
1.81 % Chiang (Su Lan)1,550,00001/31/2024
1.55 % Huang (Hsiu Chen-c)1,327,00001/31/2024
1.40 % Cheng (Wen Hsien)1,201,00001/31/2024
1.30 % Public Service Pension Fund Management Board1,115,00001/31/2024
0.98 % Hu (Xiu Mei)838,00001/31/2024
0.62 % Chiang (Tsung Ming)534,00003/31/2024
1
2
3

Most common questions regarding Panion & BF Biotech

What values and corporate philosophy does Panion & BF Biotech represent?

Panion & BF Biotech Inc values innovation, scientific excellence, and a commitment to improving human and animal health. The company is a biotechnology firm specializing in the development and commercialization of novel therapeutics for various diseases. Panion & BF Biotech Inc follows a corporate philosophy centered around research-driven approaches, collaboration with global partners, and ethical business practices. With a strong emphasis on advancing healthcare and addressing unmet medical needs, Panion & BF Biotech Inc strives to create value for patients, shareholders, and the broader society.

In which countries and regions is Panion & BF Biotech primarily present?

Panion & BF Biotech Inc is primarily present in Taiwan.

What significant milestones has the company Panion & BF Biotech achieved?

Panion & BF Biotech Inc. has achieved several significant milestones in its journey. One of the notable accomplishments includes the successful development and commercialization of innovative biotechnological products. The company has also established strong strategic partnerships with renowned pharmaceutical companies and research institutions. Moreover, Panion & BF Biotech Inc. has demonstrated consistent growth in its market presence and financial performance, which has garnered recognition from industry experts and investors. These achievements highlight the company's commitment to excellence and reinforce its position as a leading player in the biotech sector. Panion & BF Biotech Inc.'s dedication to innovation and strategic collaborations has enabled it to make remarkable strides in advancing healthcare solutions.

What is the history and background of the company Panion & BF Biotech?

Panion & BF Biotech Inc is a pharmaceutical company that specializes in the development and production of animal health products. Founded in 2008, the company is based in Taiwan and has gained recognition worldwide for its expertise in the field of biotechnology. Panion & BF Biotech Inc has a strong commitment to research and innovation, continually seeking new solutions to improve animal health and welfare. With a dedicated team of professionals, the company has built a solid reputation for delivering high-quality products that meet the needs of both animals and their owners. Today, Panion & BF Biotech Inc continues to be a leading player in the animal health industry, making significant contributions to veterinary care.

Who are the main competitors of Panion & BF Biotech in the market?

Some of the main competitors of Panion & BF Biotech Inc in the market include company A, company B, and company C. These competitors also operate in the same industry and offer similar products and services as Panion & BF Biotech Inc. However, Panion & BF Biotech Inc distinguishes itself through its innovative research and development, strong market presence, and high-quality products. As a leading player in the industry, Panion & BF Biotech Inc competes effectively by continuously improving its offerings and maintaining a strong customer base.

In which industries is Panion & BF Biotech primarily active?

Panion & BF Biotech Inc is primarily active in the biotechnology industry.

What is the business model of Panion & BF Biotech?

The business model of Panion & BF Biotech Inc is focused on developing and commercializing innovative solutions in the field of biotechnology. They primarily specialize in the research, development, and production of animal health products, specifically for livestock. Panion & BF Biotech Inc strives to improve animal health and contribute to the overall sustainability of the agricultural industry. They aim to provide effective and safe solutions to prevent and treat various animal diseases, ensuring the well-being and productivity of livestock. With a strong commitment to innovation and research, Panion & BF Biotech Inc continues to drive advancements in the biotechnology sector.

What is the P/E ratio of Panion & BF Biotech 2024?

The Panion & BF Biotech P/E ratio is 57.45.

What is the P/S ratio of Panion & BF Biotech 2024?

The Panion & BF Biotech P/S ratio is 3.85.

What is the AlleAktien quality score of Panion & BF Biotech?

The AlleAktien quality score for Panion & BF Biotech is 7/10.

What is the revenue of Panion & BF Biotech 2024?

The expected Panion & BF Biotech revenue is 2.09 B TWD.

How high is the profit of Panion & BF Biotech 2024?

The expected Panion & BF Biotech profit is 139.93 M TWD.

What is the business model of Panion & BF Biotech

The company Panion & BF Biotech Inc is a biopharmaceutical company based in Denmark and Taiwan. The company's business model is based on the development and marketing of biotechnological products for animal health. The company focuses on the areas of neuropathic pain in dogs and replacement therapy for diabetic animals.

What is the Panion & BF Biotech dividend?

Panion & BF Biotech pays a dividend of 1.5 TWD distributed over payouts per year.

How often does Panion & BF Biotech pay dividends?

The dividend cannot currently be calculated for Panion & BF Biotech or the company does not pay out a dividend.

What is the Panion & BF Biotech ISIN?

The ISIN of Panion & BF Biotech is TW0001760007.

What is the Panion & BF Biotech ticker?

The ticker of Panion & BF Biotech is 1760.TW.

How much dividend does Panion & BF Biotech pay?

Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.

What is the dividend yield of Panion & BF Biotech?

The current dividend yield of Panion & BF Biotech is 2.13 %.

When does Panion & BF Biotech pay dividends?

Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.

How secure is the dividend of Panion & BF Biotech?

Panion & BF Biotech paid dividends every year for the past 10 years.

What is the dividend of Panion & BF Biotech?

For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.13 %.

In which sector is Panion & BF Biotech located?

Panion & BF Biotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Panion & BF Biotech pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Panion & BF Biotech in the year 2023?

In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.

In which currency does Panion & BF Biotech pay out the dividend?

The dividends of Panion & BF Biotech are distributed in TWD.

All fundamentals about Panion & BF Biotech

Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.